XChange TEC.INC American Depositary Shares (XHG) fair value
Financial Services · Insurance Brokers · NASDAQ · United States
$3.79-0.26%
Market cap $196MUpdated Oct 24, 2026 · valuation updating
Our verdict
No fair value
We are missing the financial data our models need for this company. It will appear once the data arrives.
Not valued: it is pre-revenue and has no cash balance or analyst target on file.
ACCE opinionXChange TEC.INC American Depositary Shares (XHG)
Fair value
Not available
ACCE price target
$2.40
Rating
Not rated
Horizon
12 months
ACCE price target published on 20 Oct 2026, 02:20 CEST; previously $1.90 since 15 Oct 2026, 00:00 CEST.
Price used: $3.79 at the close on 23 Oct 2026, 22:00 CEST.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
56
out of 100
P/E
0.0x
forward 0.0x
1-year return
+279.0%
Dividend yield
0.00%
XChange TEC.INC American Depositary Shares in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
XHG is the American depositary share of XChange TEC, an insurance brokerage platform, and the figures available point to a business that is growing revenue at 12.6% but still runs thin, loss-making economics: a 2.4% gross margin and a -4.2% operating margin. The market values it at about $103M with no meaningful earnings, so the thesis rests on whether revenue growth can translate into operating leverage rather than on current profitability. Index membership is absent, so the name sits outside the flows that tend to support larger caps. At a score of 53/100 and with the margin profile unproven, it warrants a deeper look only if the team can see a credible path from broker revenue scale to positive operating margins; the data provided does not show that path yet.
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
severe
Negative free cash flow
Free cash flow is $-11,698, with a net margin of -22.9% and operating margin of -4.2%. The company is burning cash while its market cap is $118M.
high
Five-year revenue collapse
Five-year revenue CAGR is -80.2%, even though revenue grew 12.6% year over year. A single recent uptick does not offset a long run of shrinking sales.
high
Quality score very weak
Quality component scores 16/100, far below the other components (G:40, V:59, M:97). Profitability fundamentals are poor even where margin data looks better.
moderate
Unprofitable with zero earnings growth
Earnings YoY is +0.0% and ROE is +0.0%, with P/E at 0.0. The company is not generating reported earnings to support the valuation.
AI research notes
AI-assisted·How I use AIWritten Oct 13, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Revenue grew 12.6% year over year in the latest 10-Q, showing the top line is currently expanding.
The diluted share count fell 100.0% over the last fiscal year, which would mean no dilution pressure on existing holders.
Debt to equity sits at -0.80, meaning the balance sheet carries no conventional borrowing burden.
Why it could disappoint
Free cash flow over the last 12 months was negative at -CNY 11,698, so the business is consuming cash.
Net margin is -22.9%, meaning the company loses money on every dollar of revenue it books.
Return on equity is 0.0%, so shareholders' capital is not generating any profit for them.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where XHG's valuation models land
Price
$3.79
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores
+Score history: how each score moved over time
Analysts
Wall Street consensus
No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
+Price-target low / average / high vs the current price, with implied upside
+Forward revenue and EPS consensus by fiscal year
+ACCE fair-value models lined up against the Street
Smart Money
PRO
In one line
Trades are only made public after a delay. We show the delay so you know how old the news is.